Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy
Summary
This summary is machine-generated.Coxsackievirus B3 infection cleaves the cytoskeletal protein dystrophin, a key factor in heart muscle function. This viral protease action provides a molecular mechanism for enteroviral-induced acquired dilated cardiomyopathy.
Area Of Science
- Cardiology
- Virology
- Molecular Biology
Background
- Enteroviruses, like Coxsackievirus B3, are linked to dilated cardiomyopathy, but the underlying mechanisms remain unclear.
- Hereditary dilated cardiomyopathy involves mutations in cytoskeletal proteins like dystrophin, but its role in acquired forms is unknown.
Purpose Of The Study
- To investigate the molecular mechanism by which Coxsackievirus B3 infection leads to dilated cardiomyopathy.
- To determine if Coxsackievirus protease 2A cleaves dystrophin and if this contributes to heart muscle pathology.
Main Methods
- In vitro cleavage assays using purified Coxsackievirus protease 2A and dystrophin.
- Infection of cultured myocytes and mouse hearts with Coxsackievirus.
- Morphological analysis of dystrophin and associated proteins in infected myocytes.
Main Results
- Purified Coxsackievirus protease 2A was shown to cleave dystrophin in vitro.
- Dystrophin cleavage was observed during Coxsackievirus infection in cultured myocytes and mouse hearts.
- Infected myocytes showed morphological disruption of dystrophin, alpha-sarcoglycan, and beta-dystroglycan, indicating impaired function.
Conclusions
- Enteroviral protease 2A directly cleaves dystrophin, impairing its function.
- This viral-induced dystrophin cleavage is a key molecular mechanism in the pathogenesis of acquired dilated cardiomyopathy.
- The findings link viral infections to acquired heart failure through disruption of cytoskeletal integrity.
View abstract on PubMed